Health literacy and medication adherence in psoriasis patients: a survey in Iran.
Adherence
Health literacy
Medication
Psoriasis
Journal
BMC primary care
ISSN: 2731-4553
Titre abrégé: BMC Prim Care
Pays: England
ID NLM: 9918300889006676
Informations de publication
Date de publication:
10 05 2022
10 05 2022
Historique:
received:
22
08
2021
accepted:
25
04
2022
entrez:
10
5
2022
pubmed:
11
5
2022
medline:
14
5
2022
Statut:
epublish
Résumé
Medication adherence among Psoriasis patients is often inadequate identified as a significant problem in Psoriasis symptoms management. Poor medication adherence could necessitate stronger and more expensive medications, which could place a significant burden on the healthcare system. Moreover, the importance of health literacy assessment as a factor influencing adherence in psoriasis patients cannot be overstated. This study aimed to evaluate the medication adherence level of Iranian Psoriasis patients and its relationship with the patients' health literacy level and demographic conditions. This is a cross-sectional study among Iranian psoriasis patients conducted through a web-based questionnaire survey between 26 July 2020 and 5 January 2021 and a total of 575 samples were collected. The questionnaire consisted of 3 sections: First, demographic information and disease characteristics were evaluated. Second, the medication adherence was evaluated by using valid Morisky Medication Adherence Scale-8 (MMAS-8), and, finally, the health literacy was evaluated by using Health Literacy for Iranian Adults (HELIA). Data were analyzed using SPSS software, version 22 with descriptive statistics; Chi-square and Kruskal-Wallis tests. Stepwise multiple linear regression was also used to evaluate the impact of independent variables related on medication adherence score. Results showed that the mean health literacy score in the study population was 74.3 ± 14.23, and the mean medication adherence score was 4.1 ± 2.18. Out of the total participants, 28.8% had high health literacy, 67.1% had adequate health literacy, and 4% had inadequate health literacy. The majority of the participants (70.7%) reported low adherence, while 24.1% reported moderate and 5.2% reported high adherence. The results of the Chi-square test showed a significant relationship between age, comorbidities, type of treatment, satisfaction with treatment, the experience of adverse effects, and health literacy with medication adherence (P < 0.05 for all). The final constructed model of stepwise multiple linear regression was highly statistically significant. The highest beta coefficient in the final model belonged to the total health literacy score. Based on the results, medication adherence among Iranian psoriasis patients is low. Health literacy correlates most strongly with medication adherence and is the best variable to determine it. Improving the access to the internet and the ICTs to enhance the patients` health literacy along with developing the patient education approaches and techniques should be considered by health policymakers.
Sections du résumé
BACKGROUND
Medication adherence among Psoriasis patients is often inadequate identified as a significant problem in Psoriasis symptoms management. Poor medication adherence could necessitate stronger and more expensive medications, which could place a significant burden on the healthcare system. Moreover, the importance of health literacy assessment as a factor influencing adherence in psoriasis patients cannot be overstated. This study aimed to evaluate the medication adherence level of Iranian Psoriasis patients and its relationship with the patients' health literacy level and demographic conditions.
METHODS
This is a cross-sectional study among Iranian psoriasis patients conducted through a web-based questionnaire survey between 26 July 2020 and 5 January 2021 and a total of 575 samples were collected. The questionnaire consisted of 3 sections: First, demographic information and disease characteristics were evaluated. Second, the medication adherence was evaluated by using valid Morisky Medication Adherence Scale-8 (MMAS-8), and, finally, the health literacy was evaluated by using Health Literacy for Iranian Adults (HELIA). Data were analyzed using SPSS software, version 22 with descriptive statistics; Chi-square and Kruskal-Wallis tests. Stepwise multiple linear regression was also used to evaluate the impact of independent variables related on medication adherence score.
RESULTS
Results showed that the mean health literacy score in the study population was 74.3 ± 14.23, and the mean medication adherence score was 4.1 ± 2.18. Out of the total participants, 28.8% had high health literacy, 67.1% had adequate health literacy, and 4% had inadequate health literacy. The majority of the participants (70.7%) reported low adherence, while 24.1% reported moderate and 5.2% reported high adherence. The results of the Chi-square test showed a significant relationship between age, comorbidities, type of treatment, satisfaction with treatment, the experience of adverse effects, and health literacy with medication adherence (P < 0.05 for all). The final constructed model of stepwise multiple linear regression was highly statistically significant. The highest beta coefficient in the final model belonged to the total health literacy score.
CONCLUSIONS
Based on the results, medication adherence among Iranian psoriasis patients is low. Health literacy correlates most strongly with medication adherence and is the best variable to determine it. Improving the access to the internet and the ICTs to enhance the patients` health literacy along with developing the patient education approaches and techniques should be considered by health policymakers.
Identifiants
pubmed: 35538417
doi: 10.1186/s12875-022-01719-6
pii: 10.1186/s12875-022-01719-6
pmc: PMC9086654
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
113Informations de copyright
© 2022. The Author(s).
Références
J Dermatolog Treat. 2017 Feb;28(1):32-39
pubmed: 27151546
Br J Dermatol. 2013 Jan;168(1):20-31
pubmed: 22963128
J Dermatol. 2015 Apr;42(4):367-72
pubmed: 25720544
Lancet. 2015 Sep 5;386(9997):983-94
pubmed: 26025581
J Invest Dermatol. 2013 Feb;133(2):377-85
pubmed: 23014338
Arch Dermatol Res. 2018 Jul;310(5):443-451
pubmed: 29687328
J Dermatolog Treat. 2017 Mar;28(2):94-103
pubmed: 27180785
Patient Prefer Adherence. 2019 Dec 03;13:2029-2038
pubmed: 31819384
Am J Clin Dermatol. 2017 Apr;18(2):253-271
pubmed: 28188596
Br J Dermatol. 2019 Jun;180(6):1506-1516
pubmed: 30597532
J Clin Hypertens (Greenwich). 2008 May;10(5):348-54
pubmed: 18453793
Dermatol Ther (Heidelb). 2019 Mar;9(1):5-18
pubmed: 30578464
J Eur Acad Dermatol Venereol. 2012 Jul;26 Suppl 4:1-16
pubmed: 22725729
J Am Acad Dermatol. 2017 Mar;76(3):377-390
pubmed: 28212759
J Eur Acad Dermatol Venereol. 2017 Feb;31(2):205-212
pubmed: 27573025
JAMA Dermatol. 2015 Jun;151(6):651-8
pubmed: 25565304
Nurs Res Pract. 2012;2012:890860
pubmed: 23304484
Patient Prefer Adherence. 2016 Nov 17;10:2357-2367
pubmed: 27895471
Biomed Res Int. 2015;2015:217047
pubmed: 26539470
Int J Hypertens. 2016;2016:1508752
pubmed: 27069676
Caspian J Intern Med. 2021 Winter;12(1):77-83
pubmed: 33680402
Int J Clin Pharm. 2014 Feb;36(1):36-44
pubmed: 24293337
J Dermatolog Treat. 2019 Sep;30(6):525-528
pubmed: 29790405
J Eur Acad Dermatol Venereol. 2014 May;28 Suppl 2:4-9
pubmed: 24684738
PLoS One. 2012;7(12):e52935
pubmed: 23285231
Glob J Health Sci. 2015 Jan 01;7(4):173-83
pubmed: 25946926
Patient Prefer Adherence. 2020 Aug 07;14:1403-1409
pubmed: 32884243